Published in Gene Therapy Weekly, September 26th, 2002
Instead of using two heads, researchers have used two cholesteryl moieties to improve the uptake of phosphorothioate oligodeoxynucleotide (PS-ODN) by liver cells. The new construct drastically improves liver cell uptake without the expense of harming local nonhepatic tissues, according to the research investigators, who work at Leiden Amsterdam Center for Drug Research in Leiden.
In an earlier study, M.K. Bijsterbosch and colleagues found that a single cholesterol bound to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.